基本信息
浏览量:3
职业迁徙
个人简介
The diagnosis "metastatic cancer" is considered terminal for most cancer types. Metastatic disease therefore represents a major public health problem, affecting cancer patients and their families, as well as health care systems and the broader economy. Despite this, progress in developing treatments for metastatic disease remains slow.
The central aim of the Sleeman lab is to understand the process of metastasis and to use this knowledge to develop novel anti-cancer therapies.
The central aim of the Sleeman lab is to understand the process of metastasis and to use this knowledge to develop novel anti-cancer therapies.
研究兴趣
论文共 254 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
LIFE SCIENCE ALLIANCEno. 6 (2024)
Miguel Alberto, Lenka Kyjavova,Marc Osterland,Benedikt Kortüm,Jonathan Sleeman,Beate Rau,Ulrike Stein
European Journal of Surgical Oncologyno. 2 (2024): 107622
Simon Andreas Mayer,Benjamin Thomas,Miriam Heuer,Jan C. Brune,Volker Eras, Kilian Schuster,Leonard Knoedler, Rebecca Luisa Schaefer,Wilko Thiele,Jonathan P. Sleeman,Arno Dimmler,Patrick Heimel,Ulrich Kneser,Amir K. Bigdeli,Florian Falkner
Jonathan P. Sleeman, Jörg Haier
Clinical & Experimental Metastasisno. 3 (2024): 1-3
Clinical & experimental metastasis (2023)
crossref(2023)
crossref(2023)
Scientific reportsno. 1 (2023)
加载更多
作者统计
#Papers: 257
#Citation: 18982
H-Index: 62
G-Index: 136
Sociability: 7
Diversity: 0
Activity: 1
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn